Dayton, OH, United States of America

James Lucot

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of James Lucot

Introduction

James Lucot is an accomplished inventor based in Dayton, OH (US). He has made significant contributions to the field of medical treatments, holding a total of 4 patents. His work focuses on innovative methods for addressing health issues related to organophosphate exposure and emesis.

Latest Patents

One of Lucot's latest patents is titled "Treatment of organophosphate exposure with triptans." This patent describes a method for treating exposure to organophosphate agents and preventing morbidity through the administration of a triptan compound to a subject. Another notable patent is for "Emesis treatment," which involves a composition for treating emesis comprising 8-hydroxy-2-(dipropylamino)tetralin. This composition specifies a ratio of the S enantiomer to the R enantiomer between 2:1 and 10:1, along with a method for treating or preventing emesis using this composition.

Career Highlights

Throughout his career, Lucot has worked with various companies, including Repurposed Therapeutics, Inc. His innovative approaches have led to advancements in medical treatments, showcasing his dedication to improving health outcomes.

Collaborations

Some of his notable coworkers include David Reed Helton and David Brian Fick. Their collaboration has likely contributed to the success of Lucot's inventions and patents.

Conclusion

James Lucot's contributions to medical innovation through his patents reflect his commitment to addressing critical health challenges. His work continues to impact the field positively, demonstrating the importance of inventive solutions in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…